206 related articles for article (PubMed ID: 18709691)
1. Th1 and Th2 chemokine serum levels in systemic sclerosis in the presence or absence of autoimmune thyroiditis.
Antonelli A; Ferri C; Fallahi P; Colaci M; Giuggioli D; Ferrari SM; Frascerra S; Franzoni F; Galetta F; Ferrannini E
J Rheumatol; 2008 Sep; 35(9):1809-11. PubMed ID: 18709691
[TBL] [Abstract][Full Text] [Related]
2. CXCL10 (alpha) and CCL2 (beta) chemokines in systemic sclerosis--a longitudinal study.
Antonelli A; Ferri C; Fallahi P; Ferrari SM; Giuggioli D; Colaci M; Manfredi A; Frascerra S; Franzoni F; Galetta F; Ferrannini E
Rheumatology (Oxford); 2008 Jan; 47(1):45-9. PubMed ID: 18077490
[TBL] [Abstract][Full Text] [Related]
3. High values of alpha (CXCL10) and beta (CCL2) circulating chemokines in patients with psoriatic arthritis, in presence or absence of autoimmune thyroiditis.
Antonelli A; Fallahi P; Delle Sedie A; Ferrari SM; Maccheroni M; Bombardieri S; Riente L; Ferrannini E
Autoimmunity; 2008 Nov; 41(7):537-42. PubMed ID: 18855195
[TBL] [Abstract][Full Text] [Related]
4. Alpha-chemokine CXCL10 and beta-chemokine CCL2 serum levels in patients with hepatitis C-associated cryoglobulinemia in the presence or absence of autoimmune thyroiditis.
Antonelli A; Ferri C; Fallahi P; Ferrari SM; Frascerra S; Carpi A; Nicolini A; Ferrannini E
Metabolism; 2008 Sep; 57(9):1270-7. PubMed ID: 18702954
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of a Th1 chemoattractant IP-10 and Th2 chemoattractants, TARC and MDC, are elevated in patients with systemic sclerosis.
Fujii H; Shimada Y; Hasegawa M; Takehara K; Sato S
J Dermatol Sci; 2004 Jun; 35(1):43-51. PubMed ID: 15194146
[TBL] [Abstract][Full Text] [Related]
6. CXCL10 and CCL2 serum levels in patients with mixed cryoglobulinaemia and hepatitis C.
Antonelli A; Ferri C; Fallahi P; Ferrari SM; Frascerra S; Franzoni F; Galetta F; Zignego AL; Ferrannini E
Dig Liver Dis; 2009 Jan; 41(1):42-8. PubMed ID: 18760981
[TBL] [Abstract][Full Text] [Related]
7. Serum Th1 (CXCL10) and Th2 (CCL2) chemokine levels in children with newly diagnosed Type 1 diabetes: a longitudinal study.
Antonelli A; Fallahi P; Ferrari SM; Pupilli C; d'Annunzio G; Lorini R; Vanelli M; Ferrannini E
Diabet Med; 2008 Nov; 25(11):1349-53. PubMed ID: 19046227
[TBL] [Abstract][Full Text] [Related]
8. Th1 (CXCL10) and Th2 (CCL2) chemokine expression in patients with immune thrombocytopenia.
Gu D; Chen Z; Zhao H; Du W; Xue F; Ge J; Sui T; Wu H; Liu B; Lu S; Zhang L; Yang R
Hum Immunol; 2010 Jun; 71(6):586-91. PubMed ID: 20153790
[TBL] [Abstract][Full Text] [Related]
9. Systemic sclerosis fibroblasts show specific alterations of interferon-γ and tumor necrosis factor-α-induced modulation of interleukin 6 and chemokine ligand 2.
Antonelli A; Fallahi P; Ferrari SM; Giuggioli D; Colaci M; Di Domenicantonio A; Ferri C
J Rheumatol; 2012 May; 39(5):979-85. PubMed ID: 22422499
[TBL] [Abstract][Full Text] [Related]
10. High values of Th1 (CXCL10) and Th2 (CCL2) chemokines in patients with psoriatic arthtritis.
Antonelli A; Fallahi P; Delle Sedie A; Ferrari SM; Maccheroni M; Bombardieri S; Riente L; Ferrannini E
Clin Exp Rheumatol; 2009; 27(1):22-7. PubMed ID: 19327225
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal analysis of serum cytokine concentrations in systemic sclerosis: association of interleukin 12 elevation with spontaneous regression of skin sclerosis.
Matsushita T; Hasegawa M; Hamaguchi Y; Takehara K; Sato S
J Rheumatol; 2006 Feb; 33(2):275-84. PubMed ID: 16465658
[TBL] [Abstract][Full Text] [Related]
12. Can CCL2 serum levels be used in risk stratification or to monitor treatment response in systemic sclerosis?
Carulli MT; Handler C; Coghlan JG; Black CM; Denton CP
Ann Rheum Dis; 2008 Jan; 67(1):105-9. PubMed ID: 17604287
[TBL] [Abstract][Full Text] [Related]
13. Serum levels of the interferon-gamma-inducible alpha chemokine CXCL10 in patients with active Graves' disease, and modulation by methimazole therapy and thyroidectomy.
Antonelli A; Fallahi P; Rotondi M; Ferrari SM; Serio M; Miccoli P
Br J Surg; 2006 Oct; 93(10):1226-31. PubMed ID: 16838393
[TBL] [Abstract][Full Text] [Related]
14. High values of CXCL10 serum levels in patients with hepatitis C associated mixed cryoglobulinemia in presence or absence of autoimmune thyroiditis.
Antonelli A; Ferri C; Fallahi P; Ferrari SM; Frascerra S; Sebastiani M; Franzoni F; Galetta F; Ferrannini E
Cytokine; 2008 Apr; 42(1):137-43. PubMed ID: 18282714
[TBL] [Abstract][Full Text] [Related]
15. Alterations of serum Th1 and Th2 chemokines by combination therapy of interferon-gamma and narrowband UVB in patients with mycosis fungoides.
Shimauchi T; Sugita K; Nishio D; Isoda H; Abe S; Yamada Y; Hino R; Ogata M; Kabashima K; Tokura Y
J Dermatol Sci; 2008 Jun; 50(3):217-25. PubMed ID: 18243665
[TBL] [Abstract][Full Text] [Related]
16. High values of CXCL10 serum levels in mixed cryoglobulinemia associated with hepatitis C infection.
Antonelli A; Ferri C; Fallahi P; Ferrari SM; Sebastiani M; Ferrari D; Giunti M; Frascerra S; Tolari S; Franzoni F; Galetta F; Marchi S; Ferrannini E
Am J Gastroenterol; 2008 Oct; 103(10):2488-94. PubMed ID: 18775023
[TBL] [Abstract][Full Text] [Related]
17. Effect of the treatment with methylprednisolone on the cerebrospinal fluid and serum levels of CCL2 and CXCL10 chemokines in patients with active multiple sclerosis.
Moreira MA; Tilbery CP; Monteiro LP; Teixeira MM; Teixeira AL
Acta Neurol Scand; 2006 Aug; 114(2):109-13. PubMed ID: 16867033
[TBL] [Abstract][Full Text] [Related]
18. Serum CXCL10 levels and neuromuscular manifestations in patients with autoimmune thyroid diseases.
Cakir M; Levendoglu F; Kiyici A; Coskun Y
Autoimmunity; 2011 Sep; 44(6):496-503. PubMed ID: 21457060
[TBL] [Abstract][Full Text] [Related]
19. Chemoattractant mechanism of Th1 cells in class III and IV lupus nephritis.
Morimoto S; Tokano Y; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Suzuki J; Kaneko H; Sekigawa I; Takasaki Y
Autoimmunity; 2009 Feb; 42(2):143-9. PubMed ID: 19021013
[TBL] [Abstract][Full Text] [Related]
20. Anti-DNA topoisomerase II alpha autoantibodies in Japanese patients with systemic sclerosis.
Hayakawa I; Hasegawa M; Takehara K; Sato S
Arch Dermatol Res; 2005 Oct; 297(4):180-3. PubMed ID: 16180014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
